Without Supply Chain, radiopharmaceuticals don't reach anyone

Fluorine-18: half-life of 110 minutes. Gallium-68: 68 minutes. Astatine-211: 7.2 hours. Lutetium-177: 6.7 days.

Even for the longer-lived isotopes, every hour between production and injection is activity lost, meaning dose delivered to the patient decreases.

For the short-lived isotopes, the window is brutal. A [⁶⁸Ga]-labelled radiopharmaceutical produced at 7.00 AM may be largely unusable by 11.00 AM. A [¹⁸F]-labelled dose that leaves the production facility late due to a quality control delay may not meet specifications when it arrives at the hospital.

This is not a manufacturing problem that can be solved by producing more batches. It is a fundamental physical constraint that the entire supply chain must be designed around.
 

Global demand for radiopharmaceuticals is growing fast. Driven by expanding clinical indications, new theranostic programs, and increasing recognition of nuclear medicine's value in oncology.

Production capacity is not growing at the same pace. 

For established isotopes like [¹⁷⁷Lu] and [⁶⁸Ga], supply chains are mature but increasingly stretched. For newer isotopes like [²²⁵Ac] and [²¹¹At], supply chains are still being built from scratch.

The future will depend on how science, industry players and healthcare companies will collaborate.
 

The radiopharmacy is the production environment where radioisotopes become clinical doses. It is a highly regulated and technical space where automation, performance and reliability are key factors.

Modern radiochemistry synthesis modules automate the multi-step synthesis and purification of radiolabeled compounds, reducing operator radiation dose, improving process consistency, and enabling more complex chemistry.

Compact and flexible synthesizers are increasingly important for hospital-based and CDMO radiopharmacies that need to run multiple different products with rapid turnaround in their existing infrastructure.

The integration of automated QC, real-time monitoring, and data management systems is transforming the radiopharmacy from a highly manual environment into a more scalable operation.